“Modulation of the CB2 receptor is an interesting approach for pain and inflammation, arthritis, addictions, neuroprotection, and cancer, among other possible therapeutic applications, and is devoid of central side effects.
Structural diversity of CB2 modulator scaffolds characterized the patent literature.
Several CB2 agonists reached clinical Phase II for pain management and inflammation.
Other therapeutic applications need to be explored such as neuroprotection and/or neurodegeneration.”
http://www.ncbi.nlm.nih.gov/pubmed/27215781
